| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.92B | $4.50B | $4.13B | $3.83B | $3.80B | $3.87B | $3.75B | $3.57B |
| Cost of Revenue | $2.83B | $2.56B | $2.28B | $2.09B | $1.94B | $1.81B | $1.69B | $1.49B |
| Gross Profit | $2.10B | $1.94B | $1.85B | $1.74B | $1.86B | $2.06B | $2.05B | $2.09B |
| Gross Margin | 42.59% | 43.06% | 44.71% | 45.44% | 48.89% | 53.25% | 54.85% | 58.41% |
| Operating Expenses | $1.42B | $1.52B | $1.36B | $1.32B | $1.26B | $1.20B | $1.19B | $1.47B |
| Operating Income | $681.23M | $415.51M | $483.85M | $421.43M | $591.44M | $857.88M | $861.09M | $622.09M |
| Operating Margin | 13.83% | 9.24% | 11.72% | 11.01% | 15.58% | 22.15% | 22.99% | 17.41% |
| Net Income | $81.15M | $-40.97M | $-47.45M | $49.01M | $439.15M | $433.02M | $409.47M | $1.36B |
| Net Margin | 1.65% | -0.91% | -1.15% | 1.28% | 11.57% | 11.18% | 10.93% | 37.95% |
| EPS (Basic) | $0.20 | $-0.10 | $-0.13 | $0.13 | $1.18 | $1.18 | $1.15 | $3.82 |
| EBITDA | $1.94B | $1.95B | $1.62B | $1.72B | $1.94B | $1.90B | $1.80B | $1.95B |
| Stock Option Compensation Expense | $30.99M | $30.99M | $30.71M | $31.97M | $21.49M | $33.92M | $29.96M | $26.54M |
| Price To Earnings Ratio | 298.81 | -488.76 | -354.51 | 399.28 | 41.69 | 48.80 | 50.98 | 15.72 |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | $24.25B | $20.03B | $16.82B | $19.57B | $18.31B | $21.13B | $20.87B | $21.32B |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $26.19B | $24.73B | $24.16B | $24.72B | $23.93B | $24.69B | $22.58B | $23.95B |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $15.36B | $15.18B | $13.94B | $13.77B | $13.65B | $14.15B | $12.31B | $13.02B |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $10.77B | $9.49B | $10.15B | $10.85B | $10.18B | $10.45B | $10.22B | $10.87B |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $10.77B | $9.49B | $10.15B | $10.85B | $10.18B | $10.45B | $10.22B | $10.87B |
| Total Liabilities & Stockholders Equity | $26.19B | $24.73B | $24.16B | $24.72B | $23.93B | $24.69B | $22.58B | $23.95B |
| Book Value Per Share | $26.30 | $23.75 | $27.38 | $28.60 | $27.53 | $28.81 | $28.83 | $30.77 |
| Tangible Book Value Per Share | $23.73 | $21.14 | $24.56 | $25.84 | $24.70 | $25.93 | $25.87 | $27.84 |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 0.31% | -0.17% | -0.20% | 0.20% | 1.84% | 1.75% | 1.81% | 5.66% |
| Return on Equity | 0.75% | -0.43% | -0.47% | 0.45% | 4.31% | 4.15% | 4.01% | 12.48% |
| Return on Invested Capital | 2.74% | 1.34% | 1.49% | 1.65% | 2.61% | 3.66% | 4.02% | 2.75% |
| Quick Ratio | 1.04 | 0.73 | 0.61 | 0.62 | 1.06 | 0.72 | 0.56 | 1.03 |
| Current Ratio | 1.04 | 0.73 | 0.61 | 0.62 | 1.06 | 0.72 | 0.56 | 1.03 |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $81.15M | $-40.97M | $-47.45M | $49.01M | $439.15M | $433.02M | $409.47M | $1.36B |
| Depreciation | $1.28B | $1.41B | $1.21B | $1.22B | $1.13B | $1.07B | $2.80B | $2.50B |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $1.33B | $1.12B | $1.12B | $1.03B | $1.45B | $1.44B | $1.38B | $1.44B |
| Capital Expenditures | $603.85M | $259.42M | $454.07M | $432.97M | $528.65M | $560.65M | $462.73M | $431.64M |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | $740.33M | $723.56M | $720.32M | $686.89M | $928.81M | $1.16B | $1.13B | $827.28M |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | $0.00 | $0.00 | $1.49M | $96.00K | $0.00 | $0.00 | $1.37M | $0.00 |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | $725.78M | $860.46M | $666.09M | $593.15M | $921.53M | $877.14M | $918.73M | $1.01B |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
Why it moved over time
Market reaction stems from Ventas reporting Q2 results that beat FFO and revenue estimates and raising 2026 FFO guidance, citing strong senior-housing growth boosting expected cash flow.
Key fact: Q2 FFO $0.97 beat the $0.96 estimate; revenue also beat and Ventas raised 2026 FFO guidance citing strong senior housing performance.
seekingalpha.com: Ventas, Inc. (VTR) Q2 2026 Earnings Call TranscriptVentas' July 29 Q2 report showed FFO of $0.97 per share versus a $0.96 consensus, a beat that signals stronger-than-expected operating cash flow in its senior housing portfolio.
Key fact: Q2 FFO $0.97 per share vs $0.96 consensus
zacks.com: Ventas (VTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates